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The CA-125 antigen is expressed on a glycoprotein produced by the cells derived from the coelomic epithelium and can be detected in the pleura, pericardium, peritoneum and the Milllerian duct derivatives.' Serum CA-125 concentration is elevated in the vast majority of patients with ovarian cancer and has proved to be a very useful tumour marker in these patients. However, serum CA-125 concentrations may also be elevated in a large number of other malignant diseases such as colorectal, breast, lung and pancreatic cancer. In addition, elevated serum CA-125 concentrations may be found in other conditions, including pleural effusions and ascites irrespective of the cause. In recent years elevated serum CA-125 has also been demonstrated in patients with non-Hodgkin's Iymphoma.v? In the cases reported, no immunoreactivity for CA-125 on the lymphoma cells could be demonstrated and it was proposed that the elevated CA-125 concentration was a reactive phenomenon.t-' However, it was shown recently that lymphoma cells might secrete CA-125 under specific conditions.!" We report a case which provides further evidence that high serum CA-125 concentrations in patients with malignant lymphoma may be derived from the tumour cells.
CASE REPORT
A 48-year-old Caucasian woman was admitted with a 3-month history of diffuse bone pain. Physical examination revealed an enlarged, leftsided, supraclavicular lymph node. Laboratory investigation showed a serum lactate dehydrogenase (LDH) activity of 2790 UjL (reference range < 290 UjL) but was otherwise normal. HISTOPATHOLOGICAL FINDINGS Some fragments of the supraclavicular lymph node were snap-frozen in liquid-nitrogen-cooled isopentane and stored at -75°C until use. Other fragments were fixed in formalin for conventional histological examination. Paraffin sections were stained with haematoxylin and eosin. Immunohistological staining was performed on paraffin sections and on cryostat sections using CD45 (LCA, DAKO, Glostrup, Denmark), CD20 (L26, OAKO), COlO (CALLA, Newcastle upon Tyne, UK), CA-125 (OC-125, Thamer Diagnostica, Uithoorn, the Netherlands) and Cyclin 01 (Neomarkers, Fremont CA, USA).
The normal lymph node architecture was completely obliterated by a population of predominantly large lymphoid cells (see VIas veld et al.
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• CHOP. (a) (b) FIGURE 
Paraffin sections of tumour stained with haematoxylin and eosin, showing a diffuse population 0/ predominantly large lymphoid cells (a). CA-125 staining on cryostat sections demonstrates a moderately strong cytoplasmatic expression on the malignant cells (h).
Diffuse large B-Celllymphoma causing elevated serum CA-125 Fig. 2a ). The nuclei were large, round or ovoid, with one or multiple prominent nucleoli. Mitoses were frequent. The majority of the tumour cells expressed CD45 and CD20. No staining for Cyclin D I or CD IO was seen. A diagnosis of a diffuse large B-celllymphoma was made (REAL classification; WHO Working Formulation: diffuse large cell lymphoma, group G, intermediate grade malignancy). In view of the strongly elevated serum CA-125 concentration, we tested the expression of CA-125 on the tumour cells, with standard immunohistochemical staining. A moderately strong cytoplasmatic expression was noted on the tumour cells on the cryostat sections (see Fig. 2b ). On paraffinembedded material the staining was weaker but also discernible. It was concluded that the tumour was a CA-125-expressing diffuse large B-cell malignant lymphoma. 
DISCUSSION

CONCLUSION
I~this report we present a case of a patient with a diffuse large B-cellmalignant lymphoma with an elevated serum CA-125 concentration, without pleural or peritoneal effusions that could be responsible for the CA-125 antigen production. We demonstrated the expression of the CA-125 antigen by the malignant lymphoma tissue. As reported by others, CA-125 concentrations fell during treatment with the reduction in tumour load. 9 • 10 he pre~ence of a presumed epithelial-specific antigen, like CA-125, on lymphoma cells is however not unique; some anaplastic (Ki-I) large cell lymphomas may express the epithelial membrane antigen (EMA).11 The expression of other epithelial markers on lymphoma cells has also been recorded.P This case illustrates the limited specificity of tumour-associated antigens and stresses that immuno~istochemical diagnostic procedures must be interpreted with caution. Our findings support the in vitro observation that increased CA-125 concentrations in patients with non-Hodgkin's lymphoma may be due to production by the tumour cells.
